Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: HoodBuilder who wrote (1889)	5/1/1998 9:11:00 AM
From: Anthony Wong	Read Replies (1) \| Respond to of 9523

Thai Demand For New U.S. Impotence Drug But Approval Pending May 01, 1998 2:24 AM BANGKOK (Dow Jones)--The Thai subsidiary of a U.S. drug manufacturer says it is fielding a flood of phone calls about Viagra, the wildly popular new impotence drug, local newspapers reported Friday. However, Thailand's Food and Drug Administration has yet to give the green light to the new drug, although its manufacturer, Pfizer International, submitted it for approval in February. Demand for the drug in the U.S., manufactured by Pfizer Inc. (PFE), has been so high since it went on sale April 15 that most pharmacies are completely out of stock. Surang Runcharoen, public affairs officer for Pfizer in Bangkok said his company had received more than 50 phone calls about Viagra since its release was reported in the local media earlier this week. 'We don't get many inquiries on that scale for other medicines,' he was quoted as saying in the Bangkok Post.